SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Muhammad Ali Synthetic CCD — True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

PatientMuhammad Ali
Date of birth1942-01-17
IdentifiersMRN HR-BX001-SYN-TD; SSN (made up) 000-01-7724
Document date2026-11-01
AuthorCeleste Moreau, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Reason for Visit

Establishing primary care for Parkinson's disease: motor, non-motor, fall-risk, and orthostatic assessment. Concerns: He wants to stay steady on his feet and keep making public appearances; People in crowds have trouble hearing him because his voice is soft. [S]

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Medications

MedicationFrequencyRouteDatesStatusEvidence
Carbidopa-levodopa 25/100 mg oral tablet, one tablet by mouth three times dailyOne tablet by mouth three times daily, at about 7 a.m., noon, and 5 p.m.Oral route1984-10-01 to 1996-03-10completedS
Carbidopa-levodopa 25/100 mg oral tablet, one and a half tablets by mouth three times daily, 30 minutes before mealsOne and a half tablets (levodopa 150 mg) by mouth three times daily, 30 minutes before mealsOral route1996-03-10activeS

Procedures

ProcedureDatesStatusEvidence
Speech therapy: four-week intensive voice treatment (LSVT LOUD), 16 sessions1996-03-16 to 1996-04-10completedS
Advance care planning conversation, about 20 minutes1996-10-06 to 1996-10-06completedS

Immunizations

DateVaccineStatusEvidence
1995-10-14Influenza vaccine, 1995-1996 seasoncompletedS
1996-10-06Influenza vaccine, 1996-1997 seasoncompletedS
1996-10-06Pneumococcal conjugate vaccine PCV20completedS
1996-10-06Recombinant zoster vaccine, dose 1 of 2completedS

Past Medical History

Historical biography with true dates. These events are not part of the synthetic care timeline.

Historical dateHistoryEvidence
1981Professional boxing career with repeated blows to the head, ended by retirement in 1981; whether it caused his Parkinson's disease is disputedR (CLM-0003, CLM-0006)
1984Parkinsonian condition diagnosed in 1984, at 42, by a neurologist in New York, with slowness of movement, a masked face, decreased blinking, tremor, and a shuffling gaitD (CLM-0003, CLM-0004)

Family History

No family medical history is documented in the logged sources. Family history of real relatives is recorded only from documented or retrospective sources and is never synthesized.

Health Concerns

ConcernStatusEvidence
He wants to stay steady on his feet and keep making public appearancesactiveS
People in crowds have trouble hearing him because his voice is softactiveS

Assessment

Most recent measures: Hemoglobin [Mass/volume] in Blood 14.6 on 1996-02-10; Sodium [Moles/volume] in Serum or Plasma 140 on 1996-02-10; Potassium [Moles/volume] in Serum or Plasma 4.3 on 1996-02-10; Creatinine [Mass/volume] in Serum or Plasma 1.02 on 1996-02-10; Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1991)/1.73 sq M 87 on 1996-02-10; Glucose [Mass/volume] in Serum or Plasma 92 on 1996-02-10; Calcium [Mass/volume] in Serum or Plasma 9.5 on 1996-02-10; Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma 512 on 1996-02-10; Thyrotropin [Units/volume] in Serum or Plasma 1.8 on 1996-02-10; Total score [MoCA] 27 on 1996-02-10; Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] 3 on 1996-02-10; Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] 0 on 1996-10-06; Total score [AUDIT-C] 0 on 1996-10-06; Cholesterol [Mass/volume] in Serum or Plasma 192 on 1996-10-06; Cholesterol in HDL [Mass/volume] in Serum or Plasma 50 on 1996-10-06; Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation 118 on 1996-10-06; Triglyceride [Mass/volume] in Serum or Plasma 120 on 1996-10-06; Hemoglobin A1c/Hemoglobin.total in Blood 5.4 on 1996-10-06 [S]

Strengths and supports: Supports: spouse, adult children, and long-time friends and staff who travel with him [S]

Problems

ProblemClinical statusVerificationCodeProvenance
Parkinson's disease, young onset (diagnosed at 42), Hoehn and Yahr stage 2.5, without dyskinesia or motor fluctuationsactiveconfirmed G20.A1S — Synthetic modern coding of the publicly disclosed diagnosis; the stage and the absence of motor complications are synthetic.
Hypokinetic dysarthria with soft speech due to Parkinson's diseaseactiveconfirmed R47.1S — Synthetic modern coding of the publicly reported speech difficulty; the severity is synthetic.

Results

DateMeasureValueUnitReference rangeFlagProvenance
1996-02-10Hemoglobin [Mass/volume] in Blood14.6g/dL13.2-16.6 g/dLNormalS
1996-02-10Sodium [Moles/volume] in Serum or Plasma140mmol/L135-145 mmol/LNormalS
1996-02-10Potassium [Moles/volume] in Serum or Plasma4.3mmol/L3.5-5.1 mmol/LNormalS
1996-02-10Creatinine [Mass/volume] in Serum or Plasma1.02mg/dL0.74-1.35 mg/dLNormalS
1996-02-10Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1991)/1.73 sq M87mL/min/{1.73_m2}>=60 mL/min/1.73 m²NormalS
1996-02-10Glucose [Mass/volume] in Serum or Plasma92mg/dL70-99 mg/dLNormalS
1996-02-10Calcium [Mass/volume] in Serum or Plasma9.5mg/dL8.6-10.3 mg/dLNormalS
1996-02-10Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma512pg/mL232-1245 pg/mLNormalS
1996-02-10Thyrotropin [Units/volume] in Serum or Plasma1.8m[IU]/L0.45-4.5 mIU/LNormalS
1996-02-10Total score [MoCA]27{score}S
1996-02-10Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]3{score}S
1996-10-06Patient Health Questionnaire 2 item (PHQ-2) total score [Reported]0{score}S
1996-10-06Total score [AUDIT-C]0{score}S
1996-10-06Cholesterol [Mass/volume] in Serum or Plasma192mg/dL<=200 mg/dLNormalS
1996-10-06Cholesterol in HDL [Mass/volume] in Serum or Plasma50mg/dL>=40 mg/dLNormalS
1996-10-06Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation118mg/dL<=129 mg/dLNormalS
1996-10-06Triglyceride [Mass/volume] in Serum or Plasma120mg/dL<=149 mg/dLNormalS
1996-10-06Hemoglobin A1c/Hemoglobin.total in Blood5.4%<=5.6%NormalS

Social History

Vital Signs

DateMeasureValueUnitProvenance
1996-02-10Body height191cmS
1996-02-10Body weight102kgS
1996-02-10Body mass index (BMI) [Ratio]28kg/m2S
1996-02-10Systolic blood pressure128mm[Hg]S
1996-02-10Diastolic blood pressure78mm[Hg]S
1996-02-10Heart rate72/minS
1996-02-10Respiratory rate14/minS
1996-02-10Body temperature36.7CelS
1996-02-10Oxygen saturation in Arterial blood by Pulse oximetry98%S
1996-03-10Body height191cmS
1996-03-10Body weight102kgS
1996-03-10Body mass index (BMI) [Ratio]28kg/m2S
1996-03-10Systolic blood pressure126mm[Hg]S
1996-03-10Diastolic blood pressure78mm[Hg]S
1996-03-10Heart rate70/minS
1996-03-10Respiratory rate14/minS
1996-03-10Body temperature36.6CelS
1996-03-10Oxygen saturation in Arterial blood by Pulse oximetry98%S
1996-06-09Body height191cmS
1996-06-09Body weight101.5kgS
1996-06-09Body mass index (BMI) [Ratio]27.8kg/m2S
1996-06-09Systolic blood pressure124mm[Hg]S
1996-06-09Diastolic blood pressure76mm[Hg]S
1996-06-09Heart rate72/minS
1996-06-09Respiratory rate14/minS
1996-06-09Body temperature36.7CelS
1996-06-09Oxygen saturation in Arterial blood by Pulse oximetry98%S
1996-09-08Body height191cmS
1996-09-08Body weight101kgS
1996-09-08Body mass index (BMI) [Ratio]27.7kg/m2S
1996-09-08Systolic blood pressure126mm[Hg]S
1996-09-08Diastolic blood pressure78mm[Hg]S
1996-09-08Heart rate70/minS
1996-09-08Respiratory rate14/minS
1996-09-08Body temperature36.6CelS
1996-09-08Oxygen saturation in Arterial blood by Pulse oximetry98%S
1996-10-06Body height191cmS
1996-10-06Body weight101.2kgS
1996-10-06Body mass index (BMI) [Ratio]27.7kg/m2S
1996-10-06Systolic blood pressure124mm[Hg]S
1996-10-06Diastolic blood pressure78mm[Hg]S
1996-10-06Heart rate70/minS
1996-10-06Respiratory rate14/minS
1996-10-06Body temperature36.7CelS
1996-10-06Oxygen saturation in Arterial blood by Pulse oximetry98%S

Encounters

DatePurposeStatusProvenance
1996-02-10Establishing primary care for Parkinson's disease: motor, non-motor, fall-risk, and orthostatic assessmentfinishedS
1996-03-10Four-week follow-up with movement disorders neurology consultation for levodopa adjustment and rehabilitationfinishedS
1996-06-09Three-month Parkinson's disease review after the levodopa increase and speech therapyfinishedS
1996-09-08Six-month Parkinson's disease reviewfinishedS
1996-10-06Periodic adult preventive visitfinishedS

Plan of Treatment

InterventionStatusGuidelineProvenance
Review the levodopa dose and timing at every visit for slowness, wearing-off, and dyskinesia; take doses 30 minutes before meals; check supine and three-minute standing blood pressure after any change; avoid dopamine-blocking drugs such as metoclopramide, prochlorperazine, and most antipsychoticscompletedGL-AAN-PD-2021, GL-AAS-OH-2017, GL-CMID-2026S
Movement disorders neurology consultation to confirm the diagnosis against the MDS criteria, adjust levodopa, plan rehabilitation, and advise on genetic testingcompletedGL-MDS-CRIT-2015, GL-AAN-PD-2021, GL-CMID-2026S
Four-week intensive speech therapy (LSVT LOUD) for soft speech, and physical therapy for gait, balance, and a home exercise program of at least 150 minutes a weekcompletedGL-CMID-2026S
Monitor on the CMID schedule: motor examination, Hoehn and Yahr stage, fall check, psychosis and impulse-control questions, and medication review every visit; cognition, mood, sleep, autonomic symptoms, swallowing, speech, and driving yearly; dental examination every six monthscompletedGL-CMID-2026, GL-MDS-CRIT-2015S
Advance care planning: name a health care agent and record goals of care, and revisit with any change in stagecompletedGL-CMID-2026S

Goals

GoalTargetStatusOutcomeProvenance
Less slowness of movement after a levodopa adjustment, without dyskinesia or orthostatic hypotension, by the three-month review1996-06-09completedMDS-UPDRS Part III fell from 30 to 24; no dyskinesia; no orthostatic hypotensionS
Complete a four-week intensive speech therapy course and keep up daily voice practice1996-06-09completedLSVT LOUD course completed; easier to hear in conversation; daily home practice continuesS
No falls through the six-month review, with at least 150 minutes a week of exercise including balance work1996-09-08completedNo falls; Timed Up and Go improved from 13 to 11 seconds; exercising about 180 minutes a weekS
Name a health care agent and record his goals of care by the preventive visit1996-10-06completedHealth care agent named and goals of care recorded at the preventive visitS

Functional Status

Mental Status